Article Figures & Data
Figures
- Figure 1
Regular epilepsy service restart roadmap during and after COVID-19 pandemic.
Tables
- Table 1
Prioritization of medical care based on clinical category during COVID-19 pandemic.
Clinical Category Priority Time frame for medical care Comments Status epilepticus A Emergency Acute repetitive seizures A Emergency Unprovoked first-time seizure B 1–7 days Provoked first time seizure B 1–7 days Breakthrough seizure in known epilepsy patient (changed from baseline) B 1–7 days Breakthrough seizure in known epilepsy patient (unchanged from baseline) C 7–30 days Complex febrile seizures C 7–30 days First time simple febrile seizure C 7–30 days Known simple febrile seizures D > 30 days Regular clinical follow up Known controlled epilepsy D > 30 days Regular clinical follow up A - Potential Life-Threatening Condition
B - Urgent but not life-threatening condition
C - Not urgent but near future clinic visit is required
D - Not urgent and for regular clinic future visit
Jump to section
- Article
- Epilepsy care priorities during the COVID-19 pandemic
- Clinical follow-Up visits and telemedicine
- Access to antiepileptic medications
- COVID-19 and seizures
- Epilepsy and the risk of COVID-19
- Antiepileptic medication interactions with drugs used for COVID-19
- Epilepsy monitoring and the Epilepsy Monitoring Unit
- Electrophysiology monitoring of COVID-19 patients
- Epilepsy Surgery during the COVID-19 Pandemic
- Roadmap for resumption of full epilepsy service during and after COVID-19 pandemic
- Phase 0
- Phase I
- Phase II
- Phase III
- Case Reports
- References
- Figures & Data
- eLetters
- References
- Info & Metrics
Related Articles
Cited By...
- No citing articles found.